nodes	percent_of_prediction	percent_of_DWPC	metapath
Miglustat—UGCG—skin of body—systemic scleroderma	0.0293	0.182	CbGeAlD
Miglustat—GBA2—digestive system—systemic scleroderma	0.0238	0.148	CbGeAlD
Miglustat—UGCG—digestive system—systemic scleroderma	0.0234	0.146	CbGeAlD
Miglustat—GBA2—tendon—systemic scleroderma	0.0226	0.141	CbGeAlD
Miglustat—UGCG—tendon—systemic scleroderma	0.0223	0.139	CbGeAlD
Miglustat—GBA2—lung—systemic scleroderma	0.0199	0.123	CbGeAlD
Miglustat—UGCG—lung—systemic scleroderma	0.0196	0.122	CbGeAlD
Miglustat—Chills—Mycophenolic acid—systemic scleroderma	0.00225	0.00268	CcSEcCtD
Miglustat—Ill-defined disorder—Azathioprine—systemic scleroderma	0.00225	0.00268	CcSEcCtD
Miglustat—Decreased appetite—Mometasone—systemic scleroderma	0.00224	0.00267	CcSEcCtD
Miglustat—Weight decreased—Mycophenolate mofetil—systemic scleroderma	0.00224	0.00266	CcSEcCtD
Miglustat—Fatigue—Mometasone—systemic scleroderma	0.00222	0.00265	CcSEcCtD
Miglustat—Thrombocytopenia—Captopril—systemic scleroderma	0.00222	0.00264	CcSEcCtD
Miglustat—Back pain—Leflunomide—systemic scleroderma	0.00221	0.00264	CcSEcCtD
Miglustat—Pain—Mometasone—systemic scleroderma	0.0022	0.00263	CcSEcCtD
Miglustat—Muscle spasms—Leflunomide—systemic scleroderma	0.0022	0.00262	CcSEcCtD
Miglustat—Depression—Mycophenolate mofetil—systemic scleroderma	0.0022	0.00262	CcSEcCtD
Miglustat—Mental disorder—Mycophenolic acid—systemic scleroderma	0.0022	0.00262	CcSEcCtD
Miglustat—Malaise—Azathioprine—systemic scleroderma	0.00218	0.0026	CcSEcCtD
Miglustat—Malnutrition—Mycophenolic acid—systemic scleroderma	0.00218	0.0026	CcSEcCtD
Miglustat—Neuropathy peripheral—Mycophenolate mofetil—systemic scleroderma	0.00216	0.00257	CcSEcCtD
Miglustat—Anorexia—Captopril—systemic scleroderma	0.00216	0.00257	CcSEcCtD
Miglustat—Flatulence—Mycophenolic acid—systemic scleroderma	0.00215	0.00256	CcSEcCtD
Miglustat—Asthenia—Pentoxifylline—systemic scleroderma	0.00214	0.00255	CcSEcCtD
Miglustat—Ill-defined disorder—Leflunomide—systemic scleroderma	0.00212	0.00253	CcSEcCtD
Miglustat—Nervousness—Mycophenolic acid—systemic scleroderma	0.00212	0.00253	CcSEcCtD
Miglustat—Back pain—Mycophenolic acid—systemic scleroderma	0.00211	0.00251	CcSEcCtD
Miglustat—Gastrointestinal pain—Mometasone—systemic scleroderma	0.00211	0.00251	CcSEcCtD
Miglustat—Muscle spasms—Mycophenolic acid—systemic scleroderma	0.0021	0.0025	CcSEcCtD
Miglustat—Amnesia—Prednisone—systemic scleroderma	0.00206	0.00246	CcSEcCtD
Miglustat—Malaise—Leflunomide—systemic scleroderma	0.00206	0.00246	CcSEcCtD
Miglustat—Vertigo—Leflunomide—systemic scleroderma	0.00205	0.00245	CcSEcCtD
Miglustat—Insomnia—Captopril—systemic scleroderma	0.00205	0.00244	CcSEcCtD
Miglustat—Diarrhoea—Pentoxifylline—systemic scleroderma	0.00204	0.00244	CcSEcCtD
Miglustat—Tremor—Mycophenolic acid—systemic scleroderma	0.00204	0.00244	CcSEcCtD
Miglustat—Abdominal pain—Mometasone—systemic scleroderma	0.00204	0.00243	CcSEcCtD
Miglustat—Discomfort—Azathioprine—systemic scleroderma	0.00204	0.00243	CcSEcCtD
Miglustat—Paraesthesia—Captopril—systemic scleroderma	0.00203	0.00242	CcSEcCtD
Miglustat—Chills—Lisinopril—systemic scleroderma	0.00203	0.00241	CcSEcCtD
Miglustat—Ill-defined disorder—Mycophenolic acid—systemic scleroderma	0.00202	0.00241	CcSEcCtD
Miglustat—Dyspepsia—Captopril—systemic scleroderma	0.00199	0.00238	CcSEcCtD
Miglustat—Haemoglobin—Mycophenolate mofetil—systemic scleroderma	0.00199	0.00237	CcSEcCtD
Miglustat—Haemorrhage—Mycophenolate mofetil—systemic scleroderma	0.00198	0.00236	CcSEcCtD
Miglustat—Mental disorder—Lisinopril—systemic scleroderma	0.00198	0.00236	CcSEcCtD
Miglustat—Dizziness—Pentoxifylline—systemic scleroderma	0.00198	0.00235	CcSEcCtD
Miglustat—Decreased appetite—Captopril—systemic scleroderma	0.00197	0.00235	CcSEcCtD
Miglustat—Hypoaesthesia—Mycophenolate mofetil—systemic scleroderma	0.00197	0.00235	CcSEcCtD
Miglustat—Malaise—Mycophenolic acid—systemic scleroderma	0.00197	0.00234	CcSEcCtD
Miglustat—Malnutrition—Lisinopril—systemic scleroderma	0.00196	0.00234	CcSEcCtD
Miglustat—Vertigo—Mycophenolic acid—systemic scleroderma	0.00196	0.00234	CcSEcCtD
Miglustat—Fatigue—Captopril—systemic scleroderma	0.00195	0.00233	CcSEcCtD
Miglustat—Connective tissue disorder—Mycophenolate mofetil—systemic scleroderma	0.00194	0.00232	CcSEcCtD
Miglustat—Constipation—Captopril—systemic scleroderma	0.00194	0.00231	CcSEcCtD
Miglustat—Flatulence—Lisinopril—systemic scleroderma	0.00194	0.00231	CcSEcCtD
Miglustat—Thrombocytopenia—Azathioprine—systemic scleroderma	0.00194	0.00231	CcSEcCtD
Miglustat—Discomfort—Leflunomide—systemic scleroderma	0.00192	0.00229	CcSEcCtD
Miglustat—Nervousness—Lisinopril—systemic scleroderma	0.00191	0.00227	CcSEcCtD
Miglustat—Visual impairment—Mycophenolate mofetil—systemic scleroderma	0.00191	0.00227	CcSEcCtD
Miglustat—Dry mouth—Leflunomide—systemic scleroderma	0.0019	0.00227	CcSEcCtD
Miglustat—Back pain—Lisinopril—systemic scleroderma	0.0019	0.00227	CcSEcCtD
Miglustat—Vomiting—Pentoxifylline—systemic scleroderma	0.0019	0.00226	CcSEcCtD
Miglustat—Convulsion—Mycophenolic acid—systemic scleroderma	0.00189	0.00225	CcSEcCtD
Miglustat—Muscle spasms—Lisinopril—systemic scleroderma	0.00189	0.00225	CcSEcCtD
Miglustat—Headache—Pentoxifylline—systemic scleroderma	0.00187	0.00223	CcSEcCtD
Miglustat—Feeling abnormal—Captopril—systemic scleroderma	0.00187	0.00222	CcSEcCtD
Miglustat—Gastrointestinal pain—Captopril—systemic scleroderma	0.00185	0.00221	CcSEcCtD
Miglustat—Asthenia—Mometasone—systemic scleroderma	0.00185	0.0022	CcSEcCtD
Miglustat—Eye disorder—Mycophenolate mofetil—systemic scleroderma	0.00185	0.0022	CcSEcCtD
Miglustat—Tremor—Lisinopril—systemic scleroderma	0.00184	0.00219	CcSEcCtD
Miglustat—Discomfort—Mycophenolic acid—systemic scleroderma	0.00184	0.00219	CcSEcCtD
Miglustat—Nervous system disorder—Leflunomide—systemic scleroderma	0.00183	0.00218	CcSEcCtD
Miglustat—Thrombocytopenia—Leflunomide—systemic scleroderma	0.00183	0.00218	CcSEcCtD
Miglustat—Ill-defined disorder—Lisinopril—systemic scleroderma	0.00182	0.00217	CcSEcCtD
Miglustat—Dry mouth—Mycophenolic acid—systemic scleroderma	0.00182	0.00216	CcSEcCtD
Miglustat—Abdominal pain—Captopril—systemic scleroderma	0.00179	0.00213	CcSEcCtD
Miglustat—Anorexia—Leflunomide—systemic scleroderma	0.00178	0.00212	CcSEcCtD
Miglustat—Nausea—Pentoxifylline—systemic scleroderma	0.00177	0.00212	CcSEcCtD
Miglustat—Chills—Mycophenolate mofetil—systemic scleroderma	0.00177	0.00211	CcSEcCtD
Miglustat—Malaise—Lisinopril—systemic scleroderma	0.00177	0.00211	CcSEcCtD
Miglustat—Vertigo—Lisinopril—systemic scleroderma	0.00177	0.0021	CcSEcCtD
Miglustat—Diarrhoea—Mometasone—systemic scleroderma	0.00176	0.0021	CcSEcCtD
Miglustat—Nervous system disorder—Mycophenolic acid—systemic scleroderma	0.00175	0.00208	CcSEcCtD
Miglustat—Thrombocytopenia—Mycophenolic acid—systemic scleroderma	0.00174	0.00208	CcSEcCtD
Miglustat—Mental disorder—Mycophenolate mofetil—systemic scleroderma	0.00173	0.00206	CcSEcCtD
Miglustat—Malnutrition—Mycophenolate mofetil—systemic scleroderma	0.00172	0.00205	CcSEcCtD
Miglustat—Muscular weakness—Prednisone—systemic scleroderma	0.00171	0.00204	CcSEcCtD
Miglustat—Visual disturbance—Methotrexate—systemic scleroderma	0.00171	0.00204	CcSEcCtD
Miglustat—Gastrointestinal disorder—Azathioprine—systemic scleroderma	0.00171	0.00203	CcSEcCtD
Miglustat—Anorexia—Mycophenolic acid—systemic scleroderma	0.0017	0.00202	CcSEcCtD
Miglustat—Flatulence—Mycophenolate mofetil—systemic scleroderma	0.0017	0.00202	CcSEcCtD
Miglustat—Insomnia—Leflunomide—systemic scleroderma	0.00169	0.00201	CcSEcCtD
Miglustat—Abdominal distension—Prednisone—systemic scleroderma	0.00169	0.00201	CcSEcCtD
Miglustat—Paraesthesia—Leflunomide—systemic scleroderma	0.00168	0.002	CcSEcCtD
Miglustat—Nervousness—Mycophenolate mofetil—systemic scleroderma	0.00167	0.00199	CcSEcCtD
Miglustat—Back pain—Mycophenolate mofetil—systemic scleroderma	0.00167	0.00198	CcSEcCtD
Miglustat—Muscle spasms—Mycophenolate mofetil—systemic scleroderma	0.00166	0.00197	CcSEcCtD
Miglustat—Discomfort—Lisinopril—systemic scleroderma	0.00165	0.00197	CcSEcCtD
Miglustat—Dyspepsia—Leflunomide—systemic scleroderma	0.00164	0.00196	CcSEcCtD
Miglustat—Vomiting—Mometasone—systemic scleroderma	0.00164	0.00195	CcSEcCtD
Miglustat—Dry mouth—Lisinopril—systemic scleroderma	0.00164	0.00195	CcSEcCtD
Miglustat—Feeling abnormal—Azathioprine—systemic scleroderma	0.00163	0.00194	CcSEcCtD
Miglustat—Asthenia—Captopril—systemic scleroderma	0.00162	0.00194	CcSEcCtD
Miglustat—Decreased appetite—Leflunomide—systemic scleroderma	0.00162	0.00193	CcSEcCtD
Miglustat—Gastrointestinal pain—Azathioprine—systemic scleroderma	0.00162	0.00193	CcSEcCtD
Miglustat—Headache—Mometasone—systemic scleroderma	0.00162	0.00192	CcSEcCtD
Miglustat—Tremor—Mycophenolate mofetil—systemic scleroderma	0.00161	0.00192	CcSEcCtD
Miglustat—Gastrointestinal disorder—Leflunomide—systemic scleroderma	0.00161	0.00192	CcSEcCtD
Miglustat—Insomnia—Mycophenolic acid—systemic scleroderma	0.00161	0.00192	CcSEcCtD
Miglustat—Fatigue—Leflunomide—systemic scleroderma	0.00161	0.00192	CcSEcCtD
Miglustat—Paraesthesia—Mycophenolic acid—systemic scleroderma	0.0016	0.00191	CcSEcCtD
Miglustat—Ill-defined disorder—Mycophenolate mofetil—systemic scleroderma	0.0016	0.0019	CcSEcCtD
Miglustat—Pain—Leflunomide—systemic scleroderma	0.0016	0.0019	CcSEcCtD
Miglustat—Constipation—Leflunomide—systemic scleroderma	0.0016	0.0019	CcSEcCtD
Miglustat—Thrombocytopenia—Lisinopril—systemic scleroderma	0.00157	0.00187	CcSEcCtD
Miglustat—Dyspepsia—Mycophenolic acid—systemic scleroderma	0.00157	0.00187	CcSEcCtD
Miglustat—Abdominal pain—Azathioprine—systemic scleroderma	0.00156	0.00186	CcSEcCtD
Miglustat—Malaise—Mycophenolate mofetil—systemic scleroderma	0.00155	0.00185	CcSEcCtD
Miglustat—Diarrhoea—Captopril—systemic scleroderma	0.00155	0.00185	CcSEcCtD
Miglustat—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.00155	0.00184	CcSEcCtD
Miglustat—Vertigo—Mycophenolate mofetil—systemic scleroderma	0.00155	0.00184	CcSEcCtD
Miglustat—Feeling abnormal—Leflunomide—systemic scleroderma	0.00154	0.00183	CcSEcCtD
Miglustat—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.00154	0.00183	CcSEcCtD
Miglustat—Fatigue—Mycophenolic acid—systemic scleroderma	0.00154	0.00183	CcSEcCtD
Miglustat—Nausea—Mometasone—systemic scleroderma	0.00153	0.00183	CcSEcCtD
Miglustat—Anorexia—Lisinopril—systemic scleroderma	0.00153	0.00182	CcSEcCtD
Miglustat—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.00153	0.00182	CcSEcCtD
Miglustat—Ataxia—Methotrexate—systemic scleroderma	0.00152	0.00181	CcSEcCtD
Miglustat—Pain—Mycophenolic acid—systemic scleroderma	0.00152	0.00181	CcSEcCtD
Miglustat—Constipation—Mycophenolic acid—systemic scleroderma	0.00152	0.00181	CcSEcCtD
Miglustat—Weight decreased—Prednisone—systemic scleroderma	0.00152	0.00181	CcSEcCtD
Miglustat—Dizziness—Captopril—systemic scleroderma	0.0015	0.00178	CcSEcCtD
Miglustat—Convulsion—Mycophenolate mofetil—systemic scleroderma	0.00149	0.00178	CcSEcCtD
Miglustat—Depression—Prednisone—systemic scleroderma	0.00149	0.00177	CcSEcCtD
Miglustat—Abdominal pain—Leflunomide—systemic scleroderma	0.00148	0.00176	CcSEcCtD
Miglustat—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.00147	0.00175	CcSEcCtD
Miglustat—Neuropathy peripheral—Prednisone—systemic scleroderma	0.00146	0.00174	CcSEcCtD
Miglustat—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.00146	0.00174	CcSEcCtD
Miglustat—Insomnia—Lisinopril—systemic scleroderma	0.00145	0.00173	CcSEcCtD
Miglustat—Discomfort—Mycophenolate mofetil—systemic scleroderma	0.00145	0.00173	CcSEcCtD
Miglustat—Paraesthesia—Lisinopril—systemic scleroderma	0.00144	0.00172	CcSEcCtD
Miglustat—Vomiting—Captopril—systemic scleroderma	0.00144	0.00172	CcSEcCtD
Miglustat—Dry mouth—Mycophenolate mofetil—systemic scleroderma	0.00143	0.00171	CcSEcCtD
Miglustat—Headache—Captopril—systemic scleroderma	0.00142	0.00169	CcSEcCtD
Miglustat—Dyspepsia—Lisinopril—systemic scleroderma	0.00141	0.00168	CcSEcCtD
Miglustat—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.00141	0.00168	CcSEcCtD
Miglustat—Decreased appetite—Lisinopril—systemic scleroderma	0.00139	0.00166	CcSEcCtD
Miglustat—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.00138	0.00165	CcSEcCtD
Miglustat—Fatigue—Lisinopril—systemic scleroderma	0.00138	0.00165	CcSEcCtD
Miglustat—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	0.00138	0.00164	CcSEcCtD
Miglustat—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.00138	0.00164	CcSEcCtD
Miglustat—Pain—Lisinopril—systemic scleroderma	0.00137	0.00163	CcSEcCtD
Miglustat—Constipation—Lisinopril—systemic scleroderma	0.00137	0.00163	CcSEcCtD
Miglustat—Diarrhoea—Azathioprine—systemic scleroderma	0.00135	0.00161	CcSEcCtD
Miglustat—Haemoglobin—Prednisone—systemic scleroderma	0.00135	0.00161	CcSEcCtD
Miglustat—Nausea—Captopril—systemic scleroderma	0.00135	0.0016	CcSEcCtD
Miglustat—Haemorrhage—Prednisone—systemic scleroderma	0.00134	0.0016	CcSEcCtD
Miglustat—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.00134	0.0016	CcSEcCtD
Miglustat—Asthenia—Leflunomide—systemic scleroderma	0.00134	0.0016	CcSEcCtD
Miglustat—Feeling abnormal—Lisinopril—systemic scleroderma	0.00132	0.00157	CcSEcCtD
Miglustat—Connective tissue disorder—Prednisone—systemic scleroderma	0.00132	0.00157	CcSEcCtD
Miglustat—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.00131	0.00156	CcSEcCtD
Miglustat—Dizziness—Azathioprine—systemic scleroderma	0.00131	0.00156	CcSEcCtD
Miglustat—Asthenia—Mycophenolic acid—systemic scleroderma	0.00128	0.00152	CcSEcCtD
Miglustat—Diarrhoea—Leflunomide—systemic scleroderma	0.00128	0.00152	CcSEcCtD
Miglustat—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.00127	0.00151	CcSEcCtD
Miglustat—Abdominal pain—Lisinopril—systemic scleroderma	0.00127	0.00151	CcSEcCtD
Miglustat—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.00126	0.0015	CcSEcCtD
Miglustat—Vomiting—Azathioprine—systemic scleroderma	0.00126	0.0015	CcSEcCtD
Miglustat—Eye disorder—Prednisone—systemic scleroderma	0.00125	0.00149	CcSEcCtD
Miglustat—Depression—Methotrexate—systemic scleroderma	0.00124	0.00148	CcSEcCtD
Miglustat—Headache—Azathioprine—systemic scleroderma	0.00124	0.00148	CcSEcCtD
Miglustat—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.00124	0.00147	CcSEcCtD
Miglustat—Dizziness—Leflunomide—systemic scleroderma	0.00123	0.00147	CcSEcCtD
Miglustat—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.00122	0.00146	CcSEcCtD
Miglustat—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.00122	0.00145	CcSEcCtD
Miglustat—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.00121	0.00145	CcSEcCtD
Miglustat—Constipation—Mycophenolate mofetil—systemic scleroderma	0.0012	0.00143	CcSEcCtD
Miglustat—Pain—Mycophenolate mofetil—systemic scleroderma	0.0012	0.00143	CcSEcCtD
Miglustat—Vomiting—Leflunomide—systemic scleroderma	0.00119	0.00141	CcSEcCtD
Miglustat—Dizziness—Mycophenolic acid—systemic scleroderma	0.00118	0.0014	CcSEcCtD
Miglustat—Mental disorder—Prednisone—systemic scleroderma	0.00117	0.0014	CcSEcCtD
Miglustat—Nausea—Azathioprine—systemic scleroderma	0.00117	0.0014	CcSEcCtD
Miglustat—Headache—Leflunomide—systemic scleroderma	0.00117	0.00139	CcSEcCtD
Miglustat—Malnutrition—Prednisone—systemic scleroderma	0.00117	0.00139	CcSEcCtD
Miglustat—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.00116	0.00138	CcSEcCtD
Miglustat—Asthenia—Lisinopril—systemic scleroderma	0.00115	0.00137	CcSEcCtD
Miglustat—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.00115	0.00137	CcSEcCtD
Miglustat—Vomiting—Mycophenolic acid—systemic scleroderma	0.00113	0.00135	CcSEcCtD
Miglustat—Haemoglobin—Methotrexate—systemic scleroderma	0.00113	0.00134	CcSEcCtD
Miglustat—Haemorrhage—Methotrexate—systemic scleroderma	0.00112	0.00134	CcSEcCtD
Miglustat—Headache—Mycophenolic acid—systemic scleroderma	0.00112	0.00133	CcSEcCtD
Miglustat—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.00111	0.00132	CcSEcCtD
Miglustat—Nausea—Leflunomide—systemic scleroderma	0.00111	0.00132	CcSEcCtD
Miglustat—Diarrhoea—Lisinopril—systemic scleroderma	0.0011	0.00131	CcSEcCtD
Miglustat—Ill-defined disorder—Prednisone—systemic scleroderma	0.00108	0.00129	CcSEcCtD
Miglustat—Visual impairment—Methotrexate—systemic scleroderma	0.00108	0.00129	CcSEcCtD
Miglustat—Dizziness—Lisinopril—systemic scleroderma	0.00106	0.00126	CcSEcCtD
Miglustat—Nausea—Mycophenolic acid—systemic scleroderma	0.00106	0.00126	CcSEcCtD
Miglustat—Malaise—Prednisone—systemic scleroderma	0.00105	0.00125	CcSEcCtD
Miglustat—Vertigo—Prednisone—systemic scleroderma	0.00105	0.00125	CcSEcCtD
Miglustat—Eye disorder—Methotrexate—systemic scleroderma	0.00105	0.00125	CcSEcCtD
Miglustat—Vomiting—Lisinopril—systemic scleroderma	0.00102	0.00122	CcSEcCtD
Miglustat—Convulsion—Prednisone—systemic scleroderma	0.00101	0.00121	CcSEcCtD
Miglustat—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.00101	0.0012	CcSEcCtD
Miglustat—Chills—Methotrexate—systemic scleroderma	0.00101	0.0012	CcSEcCtD
Miglustat—Headache—Lisinopril—systemic scleroderma	0.001	0.0012	CcSEcCtD
Miglustat—Discomfort—Prednisone—systemic scleroderma	0.000982	0.00117	CcSEcCtD
Miglustat—Mental disorder—Methotrexate—systemic scleroderma	0.000982	0.00117	CcSEcCtD
Miglustat—Malnutrition—Methotrexate—systemic scleroderma	0.000975	0.00116	CcSEcCtD
Miglustat—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000961	0.00115	CcSEcCtD
Miglustat—Nausea—Lisinopril—systemic scleroderma	0.000953	0.00114	CcSEcCtD
Miglustat—Back pain—Methotrexate—systemic scleroderma	0.000943	0.00112	CcSEcCtD
Miglustat—Nervous system disorder—Prednisone—systemic scleroderma	0.000934	0.00111	CcSEcCtD
Miglustat—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000929	0.00111	CcSEcCtD
Miglustat—Anorexia—Prednisone—systemic scleroderma	0.000908	0.00108	CcSEcCtD
Miglustat—Ill-defined disorder—Methotrexate—systemic scleroderma	0.000905	0.00108	CcSEcCtD
Miglustat—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000893	0.00106	CcSEcCtD
Miglustat—Headache—Mycophenolate mofetil—systemic scleroderma	0.00088	0.00105	CcSEcCtD
Miglustat—Malaise—Methotrexate—systemic scleroderma	0.00088	0.00105	CcSEcCtD
Miglustat—Vertigo—Methotrexate—systemic scleroderma	0.000876	0.00104	CcSEcCtD
Miglustat—Insomnia—Prednisone—systemic scleroderma	0.000861	0.00103	CcSEcCtD
Miglustat—Paraesthesia—Prednisone—systemic scleroderma	0.000855	0.00102	CcSEcCtD
Miglustat—Convulsion—Methotrexate—systemic scleroderma	0.000845	0.00101	CcSEcCtD
Miglustat—Dyspepsia—Prednisone—systemic scleroderma	0.000838	0.000999	CcSEcCtD
Miglustat—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000835	0.000995	CcSEcCtD
Miglustat—Decreased appetite—Prednisone—systemic scleroderma	0.000828	0.000987	CcSEcCtD
Miglustat—Fatigue—Prednisone—systemic scleroderma	0.000821	0.000979	CcSEcCtD
Miglustat—Discomfort—Methotrexate—systemic scleroderma	0.00082	0.000978	CcSEcCtD
Miglustat—Constipation—Prednisone—systemic scleroderma	0.000814	0.000971	CcSEcCtD
Miglustat—Feeling abnormal—Prednisone—systemic scleroderma	0.000785	0.000935	CcSEcCtD
Miglustat—Nervous system disorder—Methotrexate—systemic scleroderma	0.000781	0.00093	CcSEcCtD
Miglustat—Thrombocytopenia—Methotrexate—systemic scleroderma	0.000779	0.000929	CcSEcCtD
Miglustat—Gastrointestinal pain—Prednisone—systemic scleroderma	0.000779	0.000928	CcSEcCtD
Miglustat—Anorexia—Methotrexate—systemic scleroderma	0.000759	0.000904	CcSEcCtD
Miglustat—Abdominal pain—Prednisone—systemic scleroderma	0.000753	0.000897	CcSEcCtD
Miglustat—Insomnia—Methotrexate—systemic scleroderma	0.00072	0.000858	CcSEcCtD
Miglustat—Paraesthesia—Methotrexate—systemic scleroderma	0.000715	0.000852	CcSEcCtD
Miglustat—Dyspepsia—Methotrexate—systemic scleroderma	0.000701	0.000835	CcSEcCtD
Miglustat—Decreased appetite—Methotrexate—systemic scleroderma	0.000692	0.000825	CcSEcCtD
Miglustat—Gastrointestinal disorder—Methotrexate—systemic scleroderma	0.000687	0.000819	CcSEcCtD
Miglustat—Fatigue—Methotrexate—systemic scleroderma	0.000686	0.000818	CcSEcCtD
Miglustat—Asthenia—Prednisone—systemic scleroderma	0.000683	0.000814	CcSEcCtD
Miglustat—Pain—Methotrexate—systemic scleroderma	0.000681	0.000811	CcSEcCtD
Miglustat—Feeling abnormal—Methotrexate—systemic scleroderma	0.000656	0.000782	CcSEcCtD
Miglustat—Diarrhoea—Prednisone—systemic scleroderma	0.000652	0.000777	CcSEcCtD
Miglustat—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.000651	0.000776	CcSEcCtD
Miglustat—Dizziness—Prednisone—systemic scleroderma	0.00063	0.000751	CcSEcCtD
Miglustat—Abdominal pain—Methotrexate—systemic scleroderma	0.000629	0.00075	CcSEcCtD
Miglustat—Vomiting—Prednisone—systemic scleroderma	0.000606	0.000722	CcSEcCtD
Miglustat—Headache—Prednisone—systemic scleroderma	0.000597	0.000711	CcSEcCtD
Miglustat—Asthenia—Methotrexate—systemic scleroderma	0.000571	0.000681	CcSEcCtD
Miglustat—Nausea—Prednisone—systemic scleroderma	0.000566	0.000674	CcSEcCtD
Miglustat—Diarrhoea—Methotrexate—systemic scleroderma	0.000545	0.000649	CcSEcCtD
Miglustat—Dizziness—Methotrexate—systemic scleroderma	0.000526	0.000627	CcSEcCtD
Miglustat—Vomiting—Methotrexate—systemic scleroderma	0.000506	0.000603	CcSEcCtD
Miglustat—Headache—Methotrexate—systemic scleroderma	0.000499	0.000594	CcSEcCtD
Miglustat—Nausea—Methotrexate—systemic scleroderma	0.000473	0.000563	CcSEcCtD
